A new partnership using a Nobel Prize-winning algorithm is expanding paired kidney donation in Oklahoma, giving incompatible ...
Over 200 species of flora and fauna go extinct daily. Some of these species go extinct before they are discovered. Others ...
UCLA scientists have developed a simple and cost-effective blood test that, in early studies, shows promise in detecting ...
Researchers suggest their approach has the potential to transform early disease detection and health monitoring across diverse clinical settings.
Genetic risk for inflammatory bowel disease could also help identify which patients will have a more severe disease trajectory.An evaluation of more than 8,000 Danish individuals with IBD found those ...
Market Realist on MSN
How Colossal Biosciences uses CRISPR and the safeguards behind the science
Colossal Biosciences is establishing standards for how biotechnology can responsibly support biodiversity conservation in an ...
Regeneron collaborates with TriNetX to access de-identified HER of 300 million patients to drive research and product development in life sciences and digital health solutions: Ta ...
Ascendis Receives Orphan Drug Exclusivity and Launches YUVIWEL® (Navepegritide) in the United States
YUVIWEL was granted orphan drug exclusivity by U.S. FDA to increase linear growth in pediatric patients 2 years of age and older with achondroplasia with open epiphyses - YUVIWEL is now commercially ...
Dive into 100 shocking conspiracy theories that will twist your brain! Explore historical cover-ups, hidden agendas, and mind ...
A study found that in about 10 percent of patients, WGS picked up on clinically actionable information other panels missed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results